Ranbaxy SWOT analysis evaluates the brand by its strengths, weaknesses, opportunities & threats. In SWOT Analysis of Ranbaxy, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.
Ranbaxy is one of the leading brands in the pharma and healthcare sector. The article below lists the Ranbaxy SWOT and includes its target market, segmentation, positioning & USP.
In this article:
For Ranbaxy, SWOT analysis can help the brand focus on building upon its strengths and opportunities while addressing its weaknesses as well as threats to improve its market position.
The strengths of Ranbaxy looks at the key aspects of its business which gives it competitive advantage in the market. Some important factors in a brand's strengths include its financial position, experienced workforce, product uniqueness & intangible assets like brand value.
A list of strengths is mostly the starting point in starting SWOT analysis. Below are the Strengths in the SWOT Analysis of Ranbaxy :
1.Top 10 Global Generic Company with a spread over 125 countries
2. over 13,000 well trained Employees, over 50 nationalities
3. Strong presence in the International market with a major share and a strong presence in India as well
4.It has operations in nearly 50 countries and has 7 manufacturing plants
The weaknesses of a brand are certain aspects of its business which are it can improve to increase its position further. Certain weaknesses can be defined as attributes which the company is lacking or in which the competitors are better. Here are the weaknesses in the Ranbaxy SWOT Analysis:
1. It is heavily dependent upon generics for its revenue generation
2. Constantly regulated policies by the govt means operational efficiency is affected
Read more about Ranbaxy
The opportunities for any brand can include areas of improvement to increase its business. A brand's opportunities can lie in geographic expansion, product improvements, better communication etc. Following are the opportunities in Ranbaxy SWOT Analysis:
1.increasing health awareness
2.Improvement in distribution network & brand building
3. They can leverage Synriam, anti-malarial drug in brand building
The threats for any business can be factors which can negatively impact its business. Some factors like increased competitor activity, changing government policies, alternate products or services etc. can be threats. The threats in the SWOT Analysis of Ranbaxy are as mentioned:
1.Increasingly stringent FDA Regulations
2.Exchange rate fluctuations
3.Global economic slowdown
Similar to Ranbaxy
1. Sun Pharma Industries
4. GlaxoSmithKline Pharmaceuticals Ltd
Hence this concludes the Ranbaxy SWOT analysis.
Continue reading more about the brand/company.
New boundaries, new Horizons; Trusted medicines healthier lives
It is India’s largest pharmaceutical company
Anti-Infectives, Cardiovascular & Diabetes, Dermatological, Neuro-Psychiatry, Pain management, Gastro-Intestinal, Nutritional
Healthcare professionals, wholesalers, generic distributors, and hospitals
A diversifies global healthcare company focused on patient’s needs
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Browse marketing analysis of more brands and companies similar to Ranbaxy. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
What is MBA Skool?About Us
MBA Skool is a Knowledge Resource for Management Students, Aspirants & Professionals.
Quizzes & Skills
Quizzes test your expertise in business and Skill tests evaluate your management traits
All Business Sections
Write for Us